Price: $26.39
· 1 day: -0.34% · 5 days: -2.19% · 1 month: -3.19% · YTD: +9.78%
As of 2026-11-06 21:00 UTC.
52-week range: $22.96 – $28.69 (currently at 60% of the range).
SCHF is in a downtrend, momentum soft. $26.68 is the level overhead; $25 the first support below.
5 of 6 technical checks lean bearish.
| Trend | Downtrend · below 50-day & below 200-day |
|---|---|
| Momentum | RSI 42.53 · neutral · MACD bearish |
| Trend strength | ADX 20.1 · developing |
| Location | -4.1% vs 50-day MA |
| 52-week range | -8% from high · +15% from low |
| Volatility | ATR 0.37 · ~1.4%/day |
| Level | Type | Distance |
|---|---|---|
| $26.68 (resistance) | swing zone | 1.1% |
| $26.94 (resistance) | sma 200 | 2.08% |
| $27.1 (resistance) | swing zone | 2.69% |
| $25.0 (support) | round | -5.27% |
| $22.96 (support) | 52w low | -13.0% |
| $20.0 (support) | round | -24.21% |
| RSI (14) | 42.53 | MACD | -0.1838 |
|---|---|---|---|
| ADX (14) | 20.1 | ATR (14) | 0.37 |
| 50-day average | $27.51 | 200-day average | $26.94 |
Report of 2026-11-05.
Schwab International Equity ETF (SCHF) fell 3.0% on November 5, 2026, closing at $26.68, as the broader market dropped 4.1%. The fund has now broken below its 200-day average and its 40-week average, flipping the long-term trend from up to down. The evidence points to a bearish stance for the next 2–6 weeks, but conviction is low, with only one of four conviction points met. The move is part of a broad market selloff, but SCHF's relative strength against the S&P 500 suggests the fund is not leading the decline.
The immediate trigger for the selloff is the market-wide risk-off move, with the S&P 500 falling 4.1% on the day and 3.8% over the last five days. SCHF's 5-day decline of 2.5% is less severe, indicating that the fund is holding up better than the broad market. This relative strength is notable because it suggests the international developed-market basket is not the primary source of selling pressure; instead, it is being dragged down by the overall market tone.
The debate around SCHF centers on cost and value. A Wall Street Journal article from October 16, 2026, argues that 'cheap' ETFs often carry hidden costs, particularly for investors who move beyond broad benchmarks. This is a valid concern for SCHF, which tracks the FTSE Developed ex US All Cap Index and holds nearly 4,000 stocks, as its expense ratio, while low, is not the absolute cheapest. On the other side, Morningstar highlighted three undervalued international stocks on September 22, 2026, including AstraZeneca and ASML, both of which are likely in SCHF's basket. These stocks are trading below fair value, suggesting that parts of the fund's holdings offer value.
The fund's 50-day relative performance against the S&P 500 is +0.2%, meaning it has slightly outperformed the market over that period. However, over 200 days, it trails by 2.4%. This mixed picture suggests that while the fund has not been a standout performer, it is not collapsing either. The recent peak was on October 6, 2026, at $27.60, and the fund has dropped 3.4% since then, but it remains 16.2% above its 52-week low of $22.96.
The broader backdrop includes rising bond yields and a Federal Reserve rate hike in September, which have pressured dividend-paying stocks, as noted in a CNBC article from October 6, 2026. This is relevant because international developed markets, particularly Europe and Japan, have a higher dividend yield than the US, making SCHF sensitive to yield moves. The fund's 1-month decline of 3.4% aligns with this pressure, but the 6-month change is nearly flat at +0.1%, indicating that the recent weakness is a new development.
The long-term trend has flipped. As of November 5, 2026, SCHF is trading below its 40-week average, ending the uptrend that was in place as of the October 28 report. The price is also below its 200-day average of $26.93, confirming the shift. The thesis of a neutral, range-bound market is broken; the evidence now points to a downtrend. The fund is in a phase where sellers have shown up on rallies, with the swing zone at $26.68 acting as resistance.
For the next 2–6 weeks, the balance of evidence leans negative. The daily trend runs with the weekly downtrend, and the fund is leading the S&P 500 over 50 days (+0.2%), which is against the trend, meaning it is not falling as fast as the market but is still falling. The conviction is low because only one of four conviction points is met. The strongest case against this bearish reading is that the fund has shown relative strength against the S&P 500, and the RSI at 46.03 is not oversold, leaving room for a bounce. However, this does not tip the balance because the weekly trend is down, and the price is below key averages.
The structure holds below $26.68, the swing zone where sellers have appeared on rallies. A daily close below $25.00 (round number) would confirm a downside breakout, with the next target at $22.96, the 52-week low. The stop for this breakout would be $26.77, based on the swing zone plus a quarter of the ATR. The reward-to-risk from $25.00 to $22.96 is 1.2 to 1, which does not meet the 3 to 1 threshold that makes a breakout worth the risk. To reach 3 to 1, the target would need to be closer to $20.00, which is the next round support.
The trend would end above $26.93, the 200-day average, on a weekly close above that level. This is the level that would signal that buyers are back and the downtrend is broken. Until then, the path of least resistance is lower, but the low conviction reflects the lack of a clear catalyst.
A weekly close above $26.93, the 200-day average, would change the picture from bearish to neutral or positive. This is the rule from the assessment. The one non-price fact that would do it is a shift in the macro environment, such as a pause in Fed rate hikes or a decline in bond yields, which would relieve pressure on dividend-paying international stocks.
Interactive SCHF chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs